Compare Zhongzhi Pharmaceutical Holdings Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a -19.81% CAGR growth in Operating Profits over the last 5 years
- The company is Net-Debt Free
2
Flat results in Jun 26
3
With ROE of 1.40%, it has a Very Attractive valuation with a 0.50 Price to Book Value
4
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.74%
0%
-20.74%
6 Months
-20.74%
0%
-20.74%
1 Year
-28.37%
0%
-28.37%
2 Years
-30.37%
0%
-30.37%
3 Years
-26.96%
0%
-26.96%
4 Years
-48.26%
0%
-48.26%
5 Years
-37.39%
0%
-37.39%
Zhongzhi Pharmaceutical Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.86%
EBIT Growth (5y)
-19.81%
EBIT to Interest (avg)
19.56
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.57
Tax Ratio
43.58%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.24%
ROE (avg)
12.09%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
0.50
EV to EBIT
10.69
EV to EBITDA
3.56
EV to Capital Employed
0.49
EV to Sales
0.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.60%
ROE (Latest)
1.40%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,884.30
2,401.30
-21.53%
Operating Profit (PBDIT) excl Other Income
115.70
240.60
-51.91%
Interest
5.80
7.60
-23.68%
Exceptional Items
2.60
-5.60
146.43%
Consolidate Net Profit
19.20
104.20
-81.57%
Operating Profit Margin (Excl OI)
2.40%
56.80%
-5.44%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -21.53% vs 6.02% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -81.57% vs -42.56% in Dec 2024
About Zhongzhi Pharmaceutical Holdings Ltd. 
Zhongzhi Pharmaceutical Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Footer loading






